Search Within

Arjun Vasant Balar

  1. "2011"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (4)
  2. Genitourinary Oncology Service (4)
  3. Solid Tumor Oncology Division (4)
  4. Biostatistics Service (2)
  5. Epidemiology and Biostatistics (2)
  6. Nursing (2)

More Groups

People
  1. Matthew Milowsky (5)
  2. Dean Bajorin (4)
  3. Alexia Iasonos (2)
  4. Alisa Trout (2)
  5. Ashley Regazzi (2)
  6. David Gallagher (2)

More People

Years
  1. 2011 (5)
Publications
  1. Journal of Clinical Oncology (2)
  2. BJU International (1)
  3. Journal of Pathology (1)
  4. Therapeutic Advances in Urology (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Wiley Blackwell (2)
  3. Sage Publications Ltd. (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of gemcitabine, carboplatin, and bevacizumab (Bev) in patients (pts) with advanced/metastatic urothelial carcinoma (UC)
    Meeting Abstract

    Balar, A. V.; Milowsky, M. I.; Apolo, A. B.; Ostrovnaya, I.; Iasonos, A.; Trout, A.; Regazzi, A. M.; Garcia-Grossman, I. R.; Gallagher, D. J.; Bajorin, D. F.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II trial of gemcitabine, carboplatin, and bevacizumab in chemotherapy-naive patients (Pts) with advanced/metastatic urothelial carcinoma (UC)
    Meeting Abstract

    Balar, A. V.; Milowsky, M. I.; Apolo, A. B.; Ostrovnaya, I.; Iasonos, A.; Trout, A.; Regazzi, A. M.; Garcia-Grossman, I. R.; Gallagher, D. J.; Bajorin, D. F.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?
    Journal Article

    Balar, A. V.; Milowsky, M. I.
    BJU International (2011)

    Fulltext@MSK | Save
  • Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy
    Journal Article

    Balar, A.; Bajorin, D. F.; Milowsky, M. I.
    Therapeutic Advances in Urology (2011)

    Fulltext@MSK | Save
  • Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma
    Journal Article

    Al-Ahmadie, H. A.; Iyer, G.; Janakiraman, M.; Lin, O.; Heguy, A.; Tickoo, S. K.; Fine, S. W.; Gopalan, A.; Chen, Y. B.; Balar, A.; more...
    Journal of Pathology (2011)

    Fulltext@MSK | Save